Pfizer 2Q 2Q Revenues: $11.0 billion (-9%) 2Q Earnings: $2.3 billion (-19%) YTD Revenues: $21.9 billion (-9%) YTD Earnings: $5.0 billion (-10%) Comments: Pharmaceutical sales were down 9% to $10.1 billion. The negative impact of foreign exchange accounted for a drop of $1.1 billion, or approximately 9%. U.S. revenues in 2Q09 were $4.5 billion (-5%). International revenues were $6.5 billion (-12%) and reflected operational growth of 2%, offset by a 14% unfavorable foreign exchange ...